Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes.

作者: Jana Gerstmeier , Christina Weinigel , Silke Rummler , Olof Rådmark , Oliver Werz

DOI: 10.1096/FJ.15-278010

关键词:

摘要: 5-Lipoxygenase (5-LO) catalyzes the initial steps in biosynthesis of proinflammatory leukotrienes. Upon cell activation, 5-LO translocates to nuclear membrane where arachidonic acid is transferred by 5-LO-activating protein (FLAP) for metabolism. Although previous data indicate association with FLAP, situ assembly native 5-LO/FLAP complexes remains elusive. Here, we show time-resolved colocalization immunofluorescence microscopy and interaction proximity ligation assay at Ca(2+)-ionophore A23187-activated human monocytes neutrophils relation activity. translocation product formation completed within 1.5-3 min, delayed proceeds up 30 min. Though contain comparable amounts protein, produce 3-5 times higher levels products due prolonged activity, accompanied translocation. Arachidonic seemingly acts as adaptor assembly, whereas FLAP inhibitors (MK886, 100 nM; BAY X 1005, 3 µM) disrupt complex. We conclude that may regulate activity 2 ways: first inducing an flexible efficient synthesis, followed a tight complex terminates

参考文章(48)
Fugmann B, Junge B, Müller-Peddinghaus R, Fruchtmann R, Raddatz S, Bühner K, Ahr Hj, Beckermann B, Kohlsdorfer C, Matzke M, BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics. Journal of lipid mediators. ,vol. 6, pp. 245- 248 ,(1993)
Oliver Werz, Eva Bürkert, Lutz Fischer, Dagmar Szellas, David Dishart, Bengt Samuelsson, Olof Rådmark, Dieter Steinhilber, 5-Lipoxygenase Activation by Mapkapk-2 and Erks Advances in Experimental Medicine and Biology. ,vol. 525, pp. 129- 132 ,(2003) , 10.1007/978-1-4419-9194-2_26
C Pergola, J Gerstmeier, B Mönch, B Çalışkan, S Luderer, C Weinigel, D Barz, J Maczewsky, S Pace, A Rossi, L Sautebin, E Banoglu, O Werz, The novel benzimidazole derivative BRP‐7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5‐lipoxygenase‐activating protein (FLAP) British Journal of Pharmacology. ,vol. 171, pp. 3051- 3064 ,(2014) , 10.1111/BPH.12625
C A Rouzer, S Kargman, Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. Journal of Biological Chemistry. ,vol. 263, pp. 10980- 10988 ,(1988) , 10.1016/S0021-9258(18)38066-9
S Shak, I M Goldstein, Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Journal of Biological Chemistry. ,vol. 259, pp. 10181- 10187 ,(1984) , 10.1016/S0021-9258(18)90946-4
Marc E. Surette, Nancy Dallaire, Nathalie Jean, Serge Picard, Pierre Borgeat, Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils The FASEB Journal. ,vol. 12, pp. 1521- 1531 ,(1998) , 10.1096/FASEBJ.12.14.1521
J B Summers, D H Albert, R L Bell, G W Carter, D W Brooks, J Bouska, R Dyer, P R Young, 5-lipoxygenase inhibitory activity of zileuton. Journal of Pharmacology and Experimental Therapeutics. ,vol. 256, pp. 929- 937 ,(1991)